KELLI CRANFORD: Open Payments
NPI 1528431145 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,972 in 113 payments from 10 companies in 2025. Trend: 2023 $1,756 · 2024 $1,711 · 2025 $1,972
Food & beverage: $1,972
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $776 |
| Amgen Inc. | 42 | $511 |
| Novartis Pharmaceuticals Corporation | 20 | $243 |
| Mallinckrodt Hospital Products Inc. | 6 | $213 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| Janssen Biotech, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Genentech USA, Inc. | 1 | $26 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: RINVOQ, SKYRIZI, OTEZLA, COSENTYX, ACTHAR, EVENITY, ORENCIA, ENBREL.
Industry payments across MS — which companies pay providers there.
